Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.
about
Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcriptionThe hippo signaling pathway in development and cancerIdentification and validation of oncogenes in liver cancer using an integrative oncogenomic approachDifferential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiationTransforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconEmerging role of Hippo pathway in gastric and other gastrointestinal cancersSmall-molecule SMAC mimetics as new cancer therapeuticsDiscovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancersMathematical modelling of cell-fate decision in response to death receptor engagementA systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcomaPosttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivoYAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinomaApollon modulates chemosensitivity in human esophageal squamous cell carcinoma.MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.Apoptotic cell signaling in cancer progression and therapyA novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomasOverexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancerExpression of Yes-associated protein modulates Survivin expression in primary liver malignanciesYes-associated protein regulates the hepatic response after bile duct ligationIdentification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resectionIn Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment.cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosisTwo distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation.IAP proteins as targets for drug development in oncologyThe Xq22 inversion breakpoint interrupted a novel Ras-like GTPase gene in a patient with Duchenne muscular dystrophy and profound mental retardation.Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer.Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2.TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis.The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular StressIAPs on the move: role of inhibitors of apoptosis proteins in cell migration.Genome position and gene amplificationCIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals.Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice.
P2860
Q24306110-AB653C01-46CF-437D-BD51-F775C34588A7Q24603986-70E50371-6790-4343-B15B-3CF2F3CD1F63Q24633776-65126A7C-6DC3-41E7-B9EB-C1DB142781DFQ24645394-CC2144F2-32C4-43BE-B977-0CF57F275593Q24682018-9B963625-CDC3-457B-9A29-6759F7174AF3Q26774473-6320730D-B221-4B84-9720-7EE434968AD5Q26864204-CA61D3B9-0B67-42EB-AC66-A87186DFCA54Q27678027-B86610EA-08DD-4317-A752-94767618F66EQ28213364-B0BB9565-1CF4-4852-ACA6-57A0FDC47F78Q28473094-F5CB2F88-E338-4859-A0CD-C70ACF58153EQ28482357-2A1B60B2-2EEE-4F94-BCDE-10FF629BB0C3Q33724470-4A002C89-116E-4586-9E58-95952E6E702FQ33757057-7FBD0DFF-D73F-430A-B63A-7F31473E3FAAQ33834440-A248B373-4C01-45DB-B51C-1AA1C43F1B96Q34334545-90266996-31E2-4DE6-9133-D97C4CA099A9Q34960600-8C479D56-0700-4067-8B20-19BFEFACDFF7Q35024090-BAC28280-8323-4DC2-A35F-301A0A1FF34AQ35088734-DCF94658-44E3-4007-8640-2E83A674E2FBQ35747423-140A506E-CA18-4B11-B052-39FD4A5F9E14Q35761034-22A31CFF-68F1-4B0B-B28F-8DCE6E98BCA8Q36014277-6F6CEBAB-4C84-405C-857F-508E51D5DE58Q36063654-741A4018-020C-437F-9809-6BAB053A0986Q36200492-6423865B-E9E4-41D2-A594-B6785C49AFC5Q36226478-1FD2F830-8FD1-40E8-97E6-05FF519F7FDCQ36268420-F4447ECC-E482-4244-B8DB-470332D936B9Q36274969-FC416CEE-8CD8-4E59-BDCA-33EB9A0310B7Q36737585-61FD6339-D287-4F45-97C5-A29A901FA905Q36898504-D2ED5625-167D-4D41-BB4C-F215F01AECF2Q36944175-4F8566B5-C458-4A97-9E5C-4F549968DB10Q37179796-C592976D-036A-4885-850E-2537B47B304FQ37209606-1A07A31D-6545-464E-831B-80B97EEE1DDCQ37219071-266E1B0C-2E6C-47D7-BDF3-CFA92B223D15Q37277197-5654A076-CA70-4949-8A64-6FE45A63C582Q37343955-B3F20DD4-67BA-4DE0-A2FD-EB74EB1F1C93Q37467736-6FBBE7F0-09B4-4173-A186-766FEE7A2FBDQ37512362-5471FFDB-2BFE-4963-B45A-19B49B8AA5E1Q38134633-BF980A9A-41AB-4F7A-AE31-D9F542FFC83CQ38606305-F7301BD4-C97B-41F7-800B-4FA83F2898C8Q39895118-019D23DE-D083-4A73-BC1B-C7C8CEBF71F9Q40979909-5934CE8E-489C-46AD-A817-97B5A38804E2
P2860
Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Identification of cIAP1 as a c ...... geal squamous cell carcinomas.
@en
Identification of cIAP1 as a c ...... geal squamous cell carcinomas.
@nl
type
label
Identification of cIAP1 as a c ...... geal squamous cell carcinomas.
@en
Identification of cIAP1 as a c ...... geal squamous cell carcinomas.
@nl
prefLabel
Identification of cIAP1 as a c ...... geal squamous cell carcinomas.
@en
Identification of cIAP1 as a c ...... geal squamous cell carcinomas.
@nl
P2093
P1433
P1476
Identification of cIAP1 as a c ...... ageal squamous cell carcinomas
@en
P2093
A Pimkhaokham
P304
P407
P577
2001-09-01T00:00:00Z